Draft:Magid Abou-Gharbia

Magid Abou-Gharbia
BornDecember 1, 1949
Cairo, Egypt
CitizenshipEgyptian
EducationPh.D. Organic Chemistry
Alma materTemple University
OccupationLaura H. Carnell Professor

Magid Abou-Gharbia (born December 1, 1949) is an American pharmaceutical scientist, an academician and the founding director of the Moulder Center for Drug Discovery Research.[1] He holds the position of Laura H. Carnell Professor at Temple University.[2][3]

Early life and education

edit

Magid Abou-Gharbia was born in Cairo, Egypt. He completed his B.S. in pharmacy in 1971 and his M.S. in pharmaceutical sciences in 1974 at School of Pharmacy, Cairo University. In 1979, he completed a Ph.D. in Organic chemistry from University of Pennsylvania, Philadelphia. He was the NIH Postdoctoral Fellow at Temple University, School of Pharmacy and College of Science & Technology from 1979 – 1982.[1][2]

Academic career

edit

Abou-Gharbia spent 26 years at Wyeth (now part of Pfizer) as senior vice president and head of chemical and screening sciences. Abou-Gharbia has focused on establishing research initiatives and promoting entrepreneurship within the School of Pharmacy at Temple University. He serves as the Laura H. Carnell Professor and the founding director of the Moulder Center for Drug Discovery Research[3] directed towards collaborative research efforts for the development of small molecule therapeutics for diseases.[4] Moulder Center for Drug Discovery Research has received more than $35 million in external funding from research grants and contract research, produced more than 180 publications, and filed more than 30 patents.[5] Abou-Gharbia is credited with over 140 patents and has published over 300 articles in peer-reviewed journals.[6][7]

Awards and recognition

edit

Abou-Gharbia earned following awards throughout his career:

References

edit
  1. ^ a b "power-500-2013-177.Magid Abou-Gharbia - Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More". www.arabianbusiness.com. Retrieved 2024-10-22.
  2. ^ a b "Local Experts Weigh In On Ousting Of Egyptian President - CBS Philadelphia". www.cbsnews.com. 2013-07-03. Retrieved 2024-10-22.
  3. ^ a b Wilson, Duff (26 January 2009). "For Pfizer, a Big Deal and a Test". The New York Times.
  4. ^ "Magid Abou-Gharbia". Chemical & Engineering News. Retrieved 2024-10-22.
  5. ^ Inquirer (TNS), Alison McCook-The Philadelphia (2024-10-10). "Inside the first 15 years of drug discovery at Temple". The Daily Item. Retrieved 2024-10-22.
  6. ^ "Abou-Gharbia M - Search Results - PubMed". PubMed. Retrieved 2024-10-22.
  7. ^ McCook, Alison (9 October 2024). "Inside the first 15 years of drug discovery at Temple". Inquirer. Retrieved 2024-10-22.
  8. ^ Reporter, Staff. "Hamdan medical awards announced". Khaleej Times. Retrieved 2024-10-22.
  9. ^ a b Norton, Dan (24 October 2014). "Innovation Awards: Educator / Researcher of the Year". www.bizjournals.com. Retrieved 2024-10-22.
  10. ^ "Heroes of Chemistry - Archive". American Chemical Society. Retrieved 2024-10-22.
  11. ^ "Aegerion Pharmaceuticals, Bristol-Myers Squibb, Asahi Kasei, Dow Chemical, Pfizer, And Procter & Gamble Scientists Honored For Chemical Discoveries". Chemical & Engineering News. Retrieved 2024-10-22.
  12. ^ "The Chemist | Journal of the American Institute of Chemists". www.theaic.org. Retrieved 2024-10-22.
  13. ^ a b c d "NJ's Top 10 Scientists" (PDF). Rutgers New Jersey Medical School.
  14. ^ a b "Magid Abou-gharbia Receives N.J. Inventors Hall of Fame Award, Carb Honors Three for Research". Chemical & Engineering News. Retrieved 2024-10-22.
edit


pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy